Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The binding pattern of HOXA5 in the genome of extrahepatic cholangiocarcinoma cells

ABSTRACT: The binding pattern of HOXA5 in the genome of extrahepatic cholangiocarcinoma cells

PROVIDER: PRJNA873710 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21203755_1.fastq.gz	Fastqsanger.gz
	SRR21203755_2.fastq.gz	Fastqsanger.gz
	SRR21203756_1.fastq.gz	Fastqsanger.gz
	SRR21203756_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

The binding pattern of HOXA5 in the genome of extrahepatic cholangiocarcinoma cells

Project description:HOXA5 is a transcription factor in mammalian and can regulate cell differentiation, proliferation and apoptosis as well as tumorigenesis. However, little is known on whether and how HOXA5 can regulate the malignant behaviors of cholangiocarcinoma. The binding pattern of HOXA5 was evaluated by CUT & Tag assay. The differential peaks were analysed to assess the role of HOXA5 in the regulation of the key genes involved in cell proliferation and DNA replication.

2022-10-05 | GSE212058 | GEO

The role HOXA5 in extrahepatic cholangiocarcinoma (Methylation)

Project description:Homeobox A5 (HOXA5) is a transcription factor in mammalian and can regulate cell differentiation, proliferation and apoptosis as well as tumorigenesis. However, little is known on whether and how HOXA5 can regulate the malignant behaviors of cholangiocarcinoma. The methylation levels of HOXA5 were evaluated by methylation microarray and bisulfite sequencing PCR. We found that hypermethylation in the HOXA5 promoter down-regulated HOXA5 expression in extrahepatic cholangiocarcinoma (ECCA) tissues, which was correlated with worse overall survival. HOXA5 over-expression significantly inhibited the proliferation and tumor growth.

2022-10-05 | GSE211911 | GEO

The role HOXA5 in extrahepatic cholangiocarcinoma

Project description:The role HOXA5 in extrahepatic cholangiocarcinoma

| PRJNA872542 | ENA

The role HOXA5 in extrahepatic cholangiocarcinoma (Methylation)

Project description:The role HOXA5 in extrahepatic cholangiocarcinoma (Methylation)

| PRJNA872545 | ENA

The role HOXA5 in extrahepatic cholangiocarcinoma (Expression)

Project description:The role HOXA5 in extrahepatic cholangiocarcinoma (Expression)

| PRJNA872543 | ENA

The role HOXA5 in extrahepatic cholangiocarcinoma (Expression)

Project description:Homeobox A5 (HOXA5) is a transcription factor in mammals and can regulate cell differentiation, proliferation and apoptosis as well as tumorigenesis. However, little is known about whether and how HOXA5 can regulate the malignant behaviors of cholangiocarcinoma. The expression profiles were analyzed by RNA microarray. We found MXD1 was upregulated upon HOXA5 overexpression. Besides, p53 pathway was activated by HOXA5 overexpression.

2022-10-05 | GSE211907 | GEO

Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma

Project description:Genome-wide expression analysis of 182 extrahepatic cholangiocarcinoma and 38 non-tumoral bile duct samples as part of a integrated study of gene expression and targeted DNA-sequencing in patients with extrahepatic cholangiocarcinoma We used whole-genome transcriptome to conduct an unsupervised molecular classification of extrahepatic cholangiocarcinoma

2020-03-22 | GSE132305 | GEO

Mouse extrahepatic cholangiocarcinoma study

Project description:We examined the transcriptome from bile duct tissue in mice with extrahepatic cholangiocarcinoma

2024-12-31 | GSE252380 | GEO

Mouse extrahepatic cholangiocarcinoma study

Project description:Mouse extrahepatic cholangiocarcinoma study

| PRJNA1060313 | ENA

MiR-145-5p is Down-Regulated in Human Extrahepatic Cholangiocarcinoma and Regulates SRGAP2 and Rac1

Project description:The overall objective of this study was to explore aberrantly expressed microRNAs (miRNAs) and investigate their clinical significances in patients with extrahepatic cholangiocarcinoma (ECCA).

2019-09-18 | GSE137590 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data